Jazz Pharmaceuticals Plc (JAZZ)
240.71
+0.94
(+0.39%)
USD |
NASDAQ |
Nov 17, 16:00
242.00
+1.29
(+0.54%)
After-Hours: 05:43
Jazz Pharmaceuticals Price : 240.71 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 239.63 | 242.38 | 237.85 | 240.71 | 499524.0 |
| Nov 16, 2026 | 243.30 | 244.61 | 238.94 | 239.77 | 490233.0 |
| Nov 13, 2026 | 241.77 | 243.25 | 235.89 | 241.55 | 496703.0 |
| Nov 12, 2026 | 248.96 | 249.99 | 239.60 | 240.37 | 584415.0 |
| Nov 11, 2026 | 244.24 | 248.97 | 243.76 | 248.24 | 592854.0 |
| Nov 10, 2026 | 243.55 | 246.47 | 240.77 | 245.43 | 576714.0 |
| Nov 09, 2026 | 237.10 | 244.36 | 235.14 | 243.54 | 886049.0 |
| Nov 06, 2026 | 226.66 | 237.76 | 225.50 | 234.76 | 887563.0 |
| Nov 05, 2026 | 233.20 | 234.29 | 227.05 | 227.32 | 670560.0 |
| Nov 04, 2026 | 233.23 | 234.68 | 228.45 | 234.66 | 899092.0 |
| Nov 03, 2026 | 225.37 | 234.79 | 218.52 | 229.74 | 1.681M |
| Nov 02, 2026 | 215.84 | 218.36 | 213.81 | 214.44 | 1.044M |
| Oct 30, 2026 | 209.63 | 216.62 | 209.35 | 215.98 | 1.215M |
| Oct 29, 2026 | 207.00 | 211.32 | 205.73 | 207.83 | 773589.0 |
| Oct 28, 2026 | 204.38 | 206.77 | 202.30 | 205.06 | 816165.0 |
| Oct 27, 2026 | 206.42 | 207.67 | 204.04 | 206.78 | 605813.0 |
| Oct 26, 2026 | 215.29 | 216.43 | 205.00 | 205.70 | 970044.0 |
| Oct 23, 2026 | 213.09 | 215.35 | 211.49 | 214.00 | 560601.0 |
| Oct 22, 2026 | 211.38 | 215.24 | 210.26 | 214.65 | 783806.0 |
| Oct 21, 2026 | 213.75 | 215.13 | 211.53 | 211.97 | 695908.0 |
| Oct 20, 2026 | 209.89 | 215.54 | 208.98 | 213.76 | 663267.0 |
| Oct 19, 2026 | 209.60 | 210.57 | 206.71 | 208.43 | 716948.0 |
| Oct 16, 2026 | 214.25 | 214.78 | 208.15 | 210.23 | 636712.0 |
| Oct 15, 2026 | 212.19 | 217.57 | 212.19 | 214.42 | 886417.0 |
| Oct 14, 2026 | 210.34 | 215.66 | 209.36 | 209.65 | 891561.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Avadel Pharmaceuticals Plc | 21.64 |
| GH Research Plc | 18.27 |
| Cosmo NV | 67.93 |
| Corcept Therapeutics, Inc. | 70.07 |
| Eli Lilly & Co. | 1415.55 |
Price Related Metrics
| PE Ratio | 81.65 |
| PS Ratio | 3.362 |
| Price to Book Value | 3.681 |
| Price to Free Cash Flow | 10.64 |
| Earnings Yield | 1.22% |
| Market Cap | 15.43B |
| Operating PE Ratio | 13.58 |
| Normalized PE Ratio | 19.45 |